We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNT
326
DELISTED
Verint Systems
VRNT
| $13.4M | 0.03% |
646,744
-5,753
| -0.9% | -$119K |
|
|
GRA
327
DELISTED
W.R. Grace & Co.
GRA
| $13.4M | 0.03% |
186,020
-13,011
| -7% | -$912K |
|
328
Prestige Consumer Healthcare
PBH
$2.46B
| $13.4M | 0.03% |
253,110
-28,715
| -10% | -$1.54M |
|
|
AVNS
329
DELISTED
Avanos Medical
AVNS
| $13.3M | 0.03% |
339,497
-30,766
| -8% | -$1.16M |
|
330
CSX Corp
CSX
$94.5B
| $13.3M | 0.03% |
731,901
+32,001
| +5% | +$548K |
|
|
USCR
331
DELISTED
U S Concrete, Inc.
USCR
| $13.3M | 0.03% |
169,102
-1,475
| -0.9% | -$100K |
|
|
CHUY
332
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $13.1M | 0.03% |
561,210
-19,024
| -3% | -$525K |
|
333
FedEx
FDX
$74.1B
| $13.1M | 0.03% |
60,388
-5,966
| -9% | -$1.18M |
|
334
Boston Properties
BXP
$11.3B
| $13.1M | 0.03% |
106,242
+47,191
| +80% | +$5.97M |
|
335
Lamar Advertising Co
LAMR
$16.1B
| $13.1M | 0.03% |
177,578
+22,310
| +14% | +$1.6M |
|
|
CORE
336
DELISTED
Core Mark Holding Co., Inc.
CORE
| $13.1M | 0.03% |
395,074
-4,470
| -1% | -$152K |
|
337
Insperity
NSP
$2.02B
| $13.1M | 0.03% |
367,858
+89,328
| +32% | +$3.62M |
|
|
CVSA
338
Covista Inc
CVSA
$4.42B
| $13M | 0.03% |
342,516
-3,075
| -0.9% | -$115K |
|
339
Aclaris Therapeutics
ACRS
$835M
| $13M | 0.03% |
477,617
+77,654
| +19% | +$2.11M |
|
340
Cummins
CMI
$87.8B
| $12.7M | 0.03% |
78,361
+25,038
| +47% | +$3.89M |
|
|
DERM
341
DELISTED
Dermira, Inc.
DERM
| $12.7M | 0.03% |
435,480
+12,474
| +3% | +$379K |
|
|
RTN
342
DELISTED
Raytheon Company
RTN
| $12.6M | 0.03% |
78,171
+7,618
| +11% | +$1.21M |
|
343
Ares Capital
ARCC
$14.1B
| $12.5M | 0.03% |
763,762
-53,292
| -7% | -$898K |
|
344
JB Hunt Transport Services
JBHT
$25.8B
| $12.4M | 0.03% |
135,833
-9,587
| -7% | -$847K |
|
|
PMC
345
DELISTED
PharMerica Corporation
PMC
| $12.4M | 0.03% |
471,407
-4,031
| -0.8% | -$99.1K |
|
346
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
| $12.4M | 0.03% |
223,170
-829
| -0.4% | -$1.06M |
|
347
Forum Energy Technologies
FET
$836M
| $12.3M | 0.03% |
39,582
-1,197
| -3% | -$412K |
|
|
VSM
348
DELISTED
Versum Materials, Inc.
VSM
| $12.3M | 0.03% |
378,074
-26,336
| -7% | -$822K |
|
349
Federal Agricultural Mortgage
AGM
$2.62B
| $12.3M | 0.03% |
189,650
-36,801
| -16% | -$2.23M |
|
|
BFX
350
DELISTED
BowFlex Inc.
BFX
| $12.2M | 0.03% |
637,856
-5,729
| -0.9% | -$104K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.